108 related articles for article (PubMed ID: 27385214)
21. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
Wu Y; Li J; Sun CY; Zhou Y; Zhao YF; Zhang SJ
Neoplasma; 2012; 59(3):326-32. PubMed ID: 22296502
[TBL] [Abstract][Full Text] [Related]
22. Upregulated LASP-1 correlates with a malignant phenotype and its potential therapeutic role in human cholangiocarcinoma.
Zhang H; Li Z; Chu B; Zhang F; Zhang Y; Ke F; Chen Y; Xu Y; Liu S; Zhao S; Liang H; Weng M; Wu X; Li M; Wu W; Quan Z; Liu Y; Zhang Y; Gong W
Tumour Biol; 2016 Jun; 37(6):8305-15. PubMed ID: 26729195
[TBL] [Abstract][Full Text] [Related]
23. SUMOylation of HP1α supports association with ncRNA to define responsiveness of breast cancer cells to chemotherapy.
Lin FM; Kumar S; Ren J; Karami S; Bahnassy S; Li Y; Zheng X; Wang J; Bawa-Khalfe T
Oncotarget; 2016 May; 7(21):30336-49. PubMed ID: 27107417
[TBL] [Abstract][Full Text] [Related]
24. SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway.
Kim J; Xu S; Xiong L; Yu L; Fu X; Xu Y
Oncogene; 2017 Nov; 36(46):6472-6479. PubMed ID: 28759035
[TBL] [Abstract][Full Text] [Related]
25. miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.
Ehrlich L; Hall C; Venter J; Dostal D; Bernuzzi F; Invernizzi P; Meng F; Trzeciakowski JP; Zhou T; Standeford H; Alpini G; Lairmore TC; Glaser S
Am J Pathol; 2017 Mar; 187(3):570-580. PubMed ID: 28087162
[TBL] [Abstract][Full Text] [Related]
26. An HP1 isoform-specific feedback mechanism regulates Suv39h1 activity under stress conditions.
Raurell-Vila H; Bosch-Presegue L; Gonzalez J; Kane-Goldsmith N; Casal C; Brown JP; Marazuela-Duque A; Singh PB; Serrano L; Vaquero A
Epigenetics; 2017 Feb; 12(2):166-175. PubMed ID: 28059589
[TBL] [Abstract][Full Text] [Related]
27. HP1α is a chromatin crosslinker that controls nuclear and mitotic chromosome mechanics.
Strom AR; Biggs RJ; Banigan EJ; Wang X; Chiu K; Herman C; Collado J; Yue F; Ritland Politz JC; Tait LJ; Scalzo D; Telling A; Groudine M; Brangwynne CP; Marko JF; Stephens AD
Elife; 2021 Jun; 10():. PubMed ID: 34106828
[TBL] [Abstract][Full Text] [Related]
28.
Khamko R; Daduang J; Settasatian C; Limpaiboon T
Cancer Genomics Proteomics; 2021; 18(6):771-780. PubMed ID: 34697068
[TBL] [Abstract][Full Text] [Related]
29. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.
Veeck J; Niederacher D; An H; Klopocki E; Wiesmann F; Betz B; Galm O; Camara O; Dürst M; Kristiansen G; Huszka C; Knüchel R; Dahl E
Oncogene; 2006 Jun; 25(24):3479-88. PubMed ID: 16449975
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
[TBL] [Abstract][Full Text] [Related]
31. Targeting the ∆133p53 isoform can restore chemosensitivity in 5-fluorouracil-resistant cholangiocarcinoma cells.
Nutthasirikul N; Hahnvajanawong C; Techasen A; Limpaiboon T; Leelayuwat C; Chau-In S; Jearanaikoon P
Int J Oncol; 2015 Dec; 47(6):2153-64. PubMed ID: 26459801
[TBL] [Abstract][Full Text] [Related]
32. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
[TBL] [Abstract][Full Text] [Related]
34. Significance of P-cadherin overexpression and possible mechanism of its regulation in intrahepatic cholangiocarcinoma and pancreatic cancer.
Sakamoto K; Imai K; Higashi T; Taki K; Nakagawa S; Okabe H; Nitta H; Hayashi H; Chikamoto A; Ishiko T; Beppu T; Baba H
Cancer Sci; 2015 Sep; 106(9):1153-62. PubMed ID: 26132727
[TBL] [Abstract][Full Text] [Related]
35. Phosphorylation of the linker histone H1 by CDK regulates its binding to HP1alpha.
Hale TK; Contreras A; Morrison AJ; Herrera RE
Mol Cell; 2006 Jun; 22(5):693-9. PubMed ID: 16762841
[TBL] [Abstract][Full Text] [Related]
36. Multivalency governs HP1α association dynamics with the silent chromatin state.
Kilic S; Bachmann AL; Bryan LC; Fierz B
Nat Commun; 2015 Jun; 6():7313. PubMed ID: 26084584
[TBL] [Abstract][Full Text] [Related]
37. Molecular interactions underlying the phase separation of HP1α: role of phosphorylation, ligand and nucleic acid binding.
Her C; Phan TM; Jovic N; Kapoor U; Ackermann BE; Rizuan A; Kim YC; Mittal J; Debelouchina GT
Nucleic Acids Res; 2022 Dec; 50(22):12702-12722. PubMed ID: 36537242
[TBL] [Abstract][Full Text] [Related]
38. Decrease of miR-622 expression promoted the proliferation, migration and invasion of cholangiocarcinoma cells by targeting regulation of c-Myc.
Wu YF; Li ZR; Cheng ZQ; Yin XM; Wu JS
Biomed Pharmacother; 2017 Dec; 96():7-13. PubMed ID: 28961507
[TBL] [Abstract][Full Text] [Related]
39. Loss of RB compromises specific heterochromatin modifications and modulates HP1alpha dynamics.
Siddiqui H; Fox SR; Gunawardena RW; Knudsen ES
J Cell Physiol; 2007 Apr; 211(1):131-7. PubMed ID: 17245754
[TBL] [Abstract][Full Text] [Related]
40. PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma.
Loilome W; Juntana S; Namwat N; Bhudhisawasdi V; Puapairoj A; Sripa B; Miwa M; Saya H; Riggins GJ; Yongvanit P
Int J Cancer; 2011 Jul; 129(1):34-44. PubMed ID: 20824711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
